Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
about
Obesity treatment: novel peripheral targets.Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery.Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primatesLeptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans.Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids.Obesity surgery and gut-brain communication.Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery.GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunitiesEffects of vagus nerve preservation and vagotomy on peptide YY and body weight after subtotal gastrectomyCCK-8 and CCK-58 differ in their effects on nocturnal solid meal pattern in undisturbed ratsEffects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats.Minireview: Gut peptides: targets for antiobesity drug development?Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesityThe interaction of amylin with other hormones in the control of eating.The receptive function of hypothalamic and brainstem centres to hormonal and nutrient signals affecting energy balance.Understanding synergy.New molecular targets in the pathophysiology of obesity and available treatment options under investigation.Amylin-mediated control of glycemia, energy balance, and cognition.Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.Diet-induced models of obesity (DIO) in rodents.Pulmonary delivery of peptide YY for food intake suppression and reduced body weight gain in rats.The effects of dietary fibre type on satiety-related hormones and voluntary food intake in dogs.Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.Modeling energy intake and body weight effects of a long-acting amylin analogue.Nutritive, Post-ingestive Signals Are the Primary Regulators of AgRP Neuron Activity.Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.The role of peptide YY in appetite regulation and obesity.
P2860
Q33607971-59FEC30A-DB30-4E49-80A7-B4CE5D068479Q33772412-D0A4217A-B624-4A8C-AFE1-9876868E29C2Q34150227-5E4A5AD1-E8E1-4B12-BA46-9ED278E80474Q34422087-2BEA159A-E8A3-4256-ACA4-8565A3A4690FQ35027845-2F0820CB-79E3-440A-A39A-20A5F54F58B2Q35054892-0D3184E6-831A-42FB-8C34-0F85834670C4Q35963032-8199AC07-DBB9-484C-A668-F3FB8E8618FFQ36153247-E00E917E-C7AB-40B8-B657-EBC3029CD8C8Q36166998-F1C76C35-48BD-45FF-920E-5CC3CB0AD621Q36312571-2AF31DF7-AE39-42B9-9E79-BC4A0D667C3BQ36846722-9B2AF0E8-5B3C-45FB-A486-DB99F344412EQ37210769-CDB1F5EB-909B-4DF5-8829-1C996C9AA9CDQ37254830-98896983-4371-47D5-9419-9E65C1584F94Q38031993-06BEDECD-0ADA-4355-AD91-833D2116B465Q38038929-468459C7-5B5F-4823-A212-8D7892FBA7B1Q38065010-2646F59C-DFA8-4979-B410-073C9339EBB9Q38397535-0633E6AB-7362-49AD-A12B-E17B8AAA6CE0Q38753342-6CAE3062-8933-4DF1-97C2-A3D3423C7BF0Q41944545-7FFAEC6D-DFF4-448D-B686-D6EA4903D607Q44895692-33EBA327-DF2F-4CF7-A8F0-6ED19B7DF9E0Q44962381-D6C10854-9F4C-4F48-B725-4FF0C44324BDQ46163010-23B035A9-C771-41C8-9ABF-21BCCCD5B6C2Q46535152-2B24E6F6-301C-4657-80E8-3B13205E15F6Q47175680-ACE5E73A-68A9-49C1-A294-5D1BF5BEA285Q47323373-79FFBCC0-1B17-4772-9E7B-7884C6B09776Q47329713-283C7CE3-1219-45A5-BB94-4EB35271AEB9Q47427740-264BC23A-D698-4186-A335-0A03FD3F003FQ48810891-17CCAF47-D97A-44F5-B871-7139102450EF
P2860
Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Combination therapy with amyli ...... gy and weight loss additivity.
@en
Combination therapy with amyli ...... gy and weight loss additivity.
@nl
type
label
Combination therapy with amyli ...... gy and weight loss additivity.
@en
Combination therapy with amyli ...... gy and weight loss additivity.
@nl
prefLabel
Combination therapy with amyli ...... gy and weight loss additivity.
@en
Combination therapy with amyli ...... gy and weight loss additivity.
@nl
P2093
P356
P1433
P1476
Combination therapy with amyli ...... gy and weight loss additivity.
@en
P2093
Carolyn M Jodka
Christian Weyer
Christine M Mack
David G Parkes
Holly Maier
Jennifer R Athanacio
Jonathan D Roth
Todd Coffey
P304
P356
10.1210/EN.2007-0898
P407
P577
2007-08-30T00:00:00Z